Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant, Postpartum Women, and Infants
- 1 June 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Obstetrics and Gynecology
- Vol. 55 (2), 498-509
- https://doi.org/10.1097/grf.0b013e31824f3b38
Abstract
Pertussis disease in the United States has been increasing since 1976 and many states are reporting epidemics. Pertussis is more severe in infants less than 3 months of age and is characterized by high hospital admission rates, apnea of the infant. The CDC recommends that Tdap be administered to all pregnant women after the 20th week of gestation to provide pertussis antibodies to the fetus which will offer protection against pertussis disease. Tdap is highly immunogenetic in the pregnant women and has an excellent safety profile. Tdap given to the postpartum patient and her cocoon family is an alternative strategy.Keywords
This publication has 45 references indexed in Scilit:
- Development of improved vaccines against whooping cough: current status.Human Vaccines, 2010
- Pertussis antibodies in postpartum women and their newbornsJournal of Perinatology, 2009
- Vaccines for Pertussis and Influenza: Recommendations for Use in PregnancyClinical Obstetrics and Gynecology, 2008
- Historical Comparisons of Morbidity and Mortality for Vaccine-Preventable Diseases in the United StatesJAMA, 2007
- Pertussis in Infants, Children, and Adolescents: Diagnosis, Treatment, and PreventionSeminars in Pediatric Infectious Diseases, 2006
- Societal Costs and Morbidity of Pertussis in Adolescents and AdultsClinical Infectious Diseases, 2004
- Morbidity of Pertussis in Adolescents and AdultsThe Journal of Infectious Diseases, 2000
- Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussisVaccine, 1998
- Specific immunoglobulin for treatment of whooping coughThe Lancet, 1991
- Whooping cough in adults.BMJ, 1981